Long Covid - Into the Third Year
two lab technicians working on a computer
© nortonrsx
    alt txt

    properties.trackTitle

    properties.trackSubtitle

    As the COVID-19 pandemic reaches the end of its third year, and as Covid-related mortality in North America wanes, long Covid and its disabling symptoms are attracting more attention. Some individuals report symptoms lasting more than two years, and a subset report continuing disability. 


    Long COVID – Into the Third Year, authored by Munich Re’s Dr. Tim Meagher, was recently published in the Journal of Insurance Medicine. The article provides an update on long Covid, with a particular focus on disease prevalence, disability and risk factors. It also discusses the longer-term outlook for individuals with long Covid.

     

    Contact the Author
    Tim Meagher
    Dr. Tim Meagher
    Vice President & Medical Director
    Munich Re, Canada (Life)

    Newsletter

    Subscribe to our newsletter for the latest industry research, insights on life and health-related topics, and relevant Munich Re Life US updates. Join today and stay connected with our business.